Company news
Opthea Limited news in 2016
Opthea Limited's news releases, calls and decks from 2016, newest first.
Opthea Completes Patient Enrolment in Ph1/2A wAMD Trial
November 20, 2016
Opthea receives $2.6M R&D tax incentive
October 16, 2016
Appendix 4E and Annual Report 2016
August 29, 2016
Opthea reports positive data from Phase 1 wet AMD Trial
July 25, 2016
Opthea Doses First Patient in Ph2A for OPT-302 in Wet AMD
May 4, 2016
Opthea Ph1 wAMD Trial with OPT-302 Meets Primary Objective
April 20, 2016
Circadian Capital Raising Prospectus
March 30, 2016
Opthea Completes Patient Enrolment for Phase 1 wet AMD Trial
March 29, 2016
Half Year Report and Accounts
February 25, 2016
Circadian Receives $3M R&D Tax Incentive
February 11, 2016
Circadian Board Changes and Renewal
February 10, 2016